Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.